ICD10 code of Thanatophoric Dysplasia and ICD9 code

Thanatophoric Dysplasia is classified under the ICD-10-CM code Q77.1 (Thanatophoric short stature), while in the older ICD-9-CM classification system, it was coded as 756.4. These codes are essential for clinical documentation and insurance processing for individuals affected by this severe skeletal dysplasia.

What is the clinical nature of Thanatophoric Dysplasia?

Thanatophoric Dysplasia is a severe, life-limiting skeletal disorder characterized by extreme shortening of the limbs, a narrow chest, and a large head. It is categorized into two main types based on clinical features: Type I, which presents with curved femurs and flattened vertebrae (platyspondyly), and Type II, which is distinguished by a cloverleaf-shaped skull (kleeblattschädel). Currently, 36 individuals and families affected by Thanatophoric Dysplasia have connected through the DiseaseMaps.org community to share their experiences and navigate the complexities of this diagnosis.

Is Thanatophoric Dysplasia hereditary?

Thanatophoric Dysplasia is not typically inherited from parents. It is almost exclusively caused by de novo (new) autosomal dominant mutations in the FGFR3 gene that occur during early embryonic development. Because these mutations are spontaneous, the recurrence risk for unaffected parents is generally very low, though genetic counseling is vital for families planning future pregnancies.

How is Thanatophoric Dysplasia diagnosed?

Diagnosis of Thanatophoric Dysplasia usually involves a combination of specialized medical imaging and molecular testing:

• Prenatal Ultrasound: Often reveals characteristic skeletal findings such as shortened ribs, extreme rhizomelic shortening of limbs, and macrocephaly.


• Molecular Genetic Testing: Analysis of the FGFR3 gene confirms the diagnosis by identifying specific pathogenic variants.


• Radiographic Evaluation: Postnatal assessment identifies the hallmark platyspondyly and characteristic long bone morphology.

Next steps

• Consult with a clinical geneticist to confirm the diagnosis and discuss the underlying FGFR3 mutation.


• Connect with the 36 community members on DiseaseMaps.org to find peer support and shared resources.


• Seek specialized palliative care teams if you are navigating a new diagnosis to prioritize comfort and family support.


• Contact the NIH Genetic and Rare Diseases (GARD) Information Center for comprehensive guidance on rare skeletal dysplasias.

Medical disclaimer: This information is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding your specific medical condition.

References

• Orphanet: Thanatophoric Dysplasia (ORPHA:261)


• NIH Genetic and Rare Diseases (GARD) Information Center: Thanatophoric Dysplasia


• OMIM (Online Mendelian Inheritance in Man): #187600 (Type I) and #187601 (Type II)


• DiseaseMaps.org: Global Rare Disease Community Platform